Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Acasti Pharma Current Ratio 2014-2023 | ACST

Acasti Pharma current ratio from 2014 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Acasti Pharma Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2023-12-31 $0.03B $0.00B 15.19
2023-09-30 $0.03B $0.00B 20.68
2023-06-30 $0.02B $0.00B 12.01
2023-03-31 $0.03B $0.00B 8.59
2022-12-31 $0.03B $0.00B 9.74
2022-09-30 $0.04B $0.00B 9.86
2022-06-30 $0.04B $0.00B 11.13
2022-03-31 $0.05B $0.00B 13.89
2021-12-31 $0.05B $0.00B 16.91
2021-09-30 $0.06B $0.00B 12.19
2021-06-30 $0.06B $0.00B 25.75
2021-03-31 $0.06B $0.00B 39.50
2020-12-31 $0.03B $0.00B 13.43
2020-09-30 $0.01B $0.00B 3.66
2020-06-30 $0.01B $0.01B 2.34
2020-03-31 $0.02B $0.01B 2.50
2019-12-31 $0.02B $0.01B 2.07
2019-09-30 $0.02B $0.01B 1.81
2019-06-30 $0.02B $0.01B 1.61
2019-03-31 $0.03B $0.01B 2.05
2018-12-31 $0.04B $0.01B 3.45
2018-09-30 $0.01B $0.01B 0.56
2018-06-30 $0.01B $0.01B 1.35
2018-03-31 $0.01B $0.01B 1.42
2017-12-31 $0.01B $0.00B 2.70
2017-09-30 $0.01B $0.00B 1.73
2017-06-30 $0.01B $0.00B 3.96
2017-02-28 $0.01B $0.00B 4.54
2016-11-30 $0.01B $0.00B 3.51
2016-08-31 $0.01B $0.00B 5.75
2016-05-31 $0.01B $0.00B 5.79
2016-03-31 $0.01B $0.00B 5.79
2016-02-29 $0.00B 0.00
2015-12-31 $0.01B $0.00B 9.11
2015-09-30 $0.01B $0.00B 13.53
2015-06-30 $0.02B $0.00B 8.30
2015-03-31 $0.02B $0.00B 12.15
2014-12-31 $0.02B $0.00B 10.61
2014-09-30 $0.02B $0.00B 9.43
2014-06-30 $0.02B $0.00B 12.99
2014-03-31 $0.03B $0.00B 22.05
2014-02-28 $0.00B 0.00
2013-12-31 $0.01B $0.01B 1.07
2013-09-30 $0.01B $0.00B 1.30
2013-06-30 $0.01B $0.00B 1.72
2013-03-31 $0.01B $0.00B 2.40
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.027B $0.000B
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.482B 5.59
Dr Reddy's Laboratories (RDY) India $12.441B 19.67
Aspen Pharmacare (APNHY) South Africa $5.038B 0.00
BridgeBio Pharma (BBIO) United States $4.375B 0.00
Bausch Health Cos (BHC) Canada $3.183B 2.48
Amphastar Pharmaceuticals (AMPH) United States $2.009B 13.75
Supernus Pharmaceuticals (SUPN) United States $1.646B 0.00
Taysha Gene Therapies (TSHA) United States $0.447B 0.00
Generation Bio (GBIO) United States $0.193B 0.00
Assembly Biosciences (ASMB) United States $0.069B 0.00
Personalis (PSNL) United States $0.064B 0.00
Sol-Gel Technologies (SLGL) Israel $0.025B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00